I. Pavord, M. Castro, K. Rabe, N. Hanania, A. Papi, J. Fitzgerald, M. Rice, P. Rowe, Y. Lu, N. Amin, H. Staudinger, N. Graham, A. Teper
{"title":"在LIBERTY Asthma QUEST研究中,Dupilumab可降低中重度哮喘患者的严重恶化并改善肺功能,无论基线支气管扩张剂可逆性如何","authors":"I. Pavord, M. Castro, K. Rabe, N. Hanania, A. Papi, J. Fitzgerald, M. Rice, P. Rowe, Y. Lu, N. Amin, H. Staudinger, N. Graham, A. Teper","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2624","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":104393,"journal":{"name":"B15. IMMUNOTHERAPY FOR LUNG DISEASE","volume":"349 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Dupilumab Reduces Severe Exacerbations and Improves Lung Function Regardless of Baseline Bronchodilator Reversibility in Patients with Uncontrolled Moderate-to-Severe Asthma Enrolled in the LIBERTY ASTHMA QUEST Study\",\"authors\":\"I. Pavord, M. Castro, K. Rabe, N. Hanania, A. Papi, J. Fitzgerald, M. Rice, P. Rowe, Y. Lu, N. Amin, H. Staudinger, N. Graham, A. Teper\",\"doi\":\"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2624\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":104393,\"journal\":{\"name\":\"B15. IMMUNOTHERAPY FOR LUNG DISEASE\",\"volume\":\"349 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"B15. IMMUNOTHERAPY FOR LUNG DISEASE\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2624\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"B15. IMMUNOTHERAPY FOR LUNG DISEASE","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2624","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Dupilumab Reduces Severe Exacerbations and Improves Lung Function Regardless of Baseline Bronchodilator Reversibility in Patients with Uncontrolled Moderate-to-Severe Asthma Enrolled in the LIBERTY ASTHMA QUEST Study